TheralinkTheralink

  • Theralink
    • The Theralink platform
    • The Theralink Assay
    • Request RPPA Analyte List
    • RPPA Clinical Publications
    • RPPA Research Publications
    • RPPA Technical Publications
  • About
    • Overview
    • Oncologists
    • Mission Statement
    • Management Team
    • Medical Advisory Board
    • Scientific Advisory Board
    • Board of Directors
  • News & Media
    • Press Releases
    • Media & Articles
    • Theralink Blog
  • Biopharmas
    • Overview
    • Explore Technology
    • Explore Targets
    • Explore Pathways
    • Request Pathway Quote
    • Conference Abstracts
    • FAQ
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Investor Resources
      • FAQ
      • Contacts Us
    • Corporate Governance
      • Management Team
      • Medical Advisory Board
      • Scientific Advisory Board
      • Board of Directors
  • Contacts

Media & Articles

Theralink   →  Media & Articles

Media & Articles

Media & Articles

Post on June 22nd, 2022

Live Webinar with Mick Ruxin, M.D.

Post on June 20th, 2022

Sequire Spotlight Presents Theralink Technologies

Post on May 3rd, 2022

Opportunities for Proteomics in The Community Oncology Setting

Post on october 9th, 2020

Breast Cancer Awareness Month

Media & Articles

  • Press Releases
  • Media & Articles
Theralink Technologies intends to be a market leader in precision medicine for more effective cancer treatments

Menu

  • About
  • Investors
  • Contact
  • Privacy Policy

OUR SERVICES

  • Biopharmas
  • Oncologists
  • Media Room

Press Releases

  • Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer
  • Theralink® Technologies to Host Fireside Chat with Dr. Mick Ruxin on June 22nd at 11:00 a.m. ET
  • Theralink® Technologies Expands Adoption of its Precision Medicine Technology in the Biopharmaceutical Industry
Copyright © 2022 Theralink. All rights reserved.